BV Baltic
Drug registry with results analysis for brentuximab vedotin in Polish CTCL patients.
PROSPECTIVE OBSERVATIONAL STUDY
To begin entering registration data, please enter the access code and then click
"Register"
.
Access key
BioStat
®
company oversees the smooth course
of the study and data analysis.
Any questions should be directed to the Organizer's office.
BioStat Sp. z o.o.
Kowalczyka 17, 44-206 Rybnik
tel: 666 069 814
email:
[email protected]
The study is sponsored by
Takeda Pharma sp. z o.o.
Takeda Pharma sp. z o.o.
Prosta 68, 00-838 Warszawa
tel: + 48 22 608 13 00/01
fax: + 48 22 608 13 03
VV-MEDCOM-19832
FAQ / Polityka Prywatności / Cookies
